Current:Home > StocksAfter US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen -FutureFinance
After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
View
Date:2025-04-16 05:35:56
TOKYO (AP) — Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies. It’s the first drug for treatment of the disease in a country with a rapidly aging population.
Developed by Japanese drugmaker Eisai Co. and U.S. biotechnology firm Biogen Inc., the drug’s approval in Japan comes two months after it was endorsed by the U.S. Food and Drug Administration.
Leqembi is for patients with mild dementia and other symptoms in the early stages of Alzheimer’s disease, and the first medicine that can modestly slow their cognitive decline.
Prime Minister Fumio Kishida, who announced Japan’s approval of Leqembi on Monday, called it “a breakthrough” and said that the “treatment of dementia has now entered a new era.”
Kishida has pledged to step up support for the growing number of dementia patients and their families and is due to launch a panel this week to discuss measures for a dementia-friendly society.
According to the health ministry, Japan’s number of dementia patients who are 65 years of age or older will rise to 7 million in 2025, from the current 6 million.
The drug, however, does not work for everyone and — as with other Alzheimer’s drugs that target plaques in the brain — can cause dangerous side effects such as brain swelling and bleeding in rare cases.
Eisai said it will conduct a post-marketing special use survey in all patients administered the drug until enough data is collected from unspecified number of patients under Japanese health ministry procedures.
The drug will be partially covered by health insurance and is expected to be ready for clinical use by the end of the year. The price is yet to be decided but is expected to be expensive, Kyodo News agency reported.
Eisai is committed to delivering Leqembi to people who need it and their families “as a new treatment,” said Haruo Naito, the company’s CEO.
“We aim to create impact on issues surrounding dementia in Japanese society,” he said.
veryGood! (92)
Related
- California DMV apologizes for license plate that some say mocks Oct. 7 attack on Israel
- Shell plans to increase fossil fuel production despite its net-zero pledge
- Take 20% Off the Cult Favorite Outdoor Voices Exercise Dress in Honor of Its 5-Year Anniversary
- It's National Tequila Day 2023: See deals, recipes and drinks to try
- New Zealand official reverses visa refusal for US conservative influencer Candace Owens
- Inside Clean Energy: Navigating the U.S. Solar Industry’s Spring of Discontent
- How Jill Duggar Is Parenting Her Own Way Apart From Her Famous Family
- Hey Girl, You Need to Hear the Cute AF Compliment Ryan Gosling Just Gave Eva Mendes
- Nearly half of US teens are online ‘constantly,’ Pew report finds
- Why Filming This Barbie Scene Was the Worst Day of Issa Rae’s Life
Ranking
- IRS recovers $4.7 billion in back taxes and braces for cuts with Trump and GOP in power
- Taylor Swift Reunites With Taylor Lautner in I Can See You Video and Onstage
- Powering Electric Cars: the Race to Mine Lithium in America’s Backyard
- Megan Rapinoe Announces Plans to Retire From Professional Soccer
- Sonya Massey's father decries possible release of former deputy charged with her death
- China owns 380,000 acres of land in the U.S. Here's where
- Environmentalists Fear a Massive New Plastics Plant Near Pittsburgh Will Worsen Pollution and Stimulate Fracking
- One Direction's Liam Payne Completes 100-Day Rehab Stay After Life-Changing Moment
Recommendation
Small twin
Untangling All the Controversy Surrounding Colleen Ballinger
Harry Styles Reacts to Tennis Star Elina Monfils Giving Up Concert Tickets Amid Wimbledon Run
'He will be sadly missed': Drag race driver killed in high-speed crash in Ohio
Spooky or not? Some Choa Chu Kang residents say community garden resembles cemetery
Trisha Paytas Announces End of Podcast With Colleen Ballinger Amid Controversy
In Texas, a New Study Will Determine Where Extreme Weather Hazards and Environmental Justice Collide
He lost $340,000 to a crypto scam. Such cases are on the rise